Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 4 studies | 40% ± 15% |
Insufficient scRNA-seq data for expression of GCGR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 8872.53 | 226 / 226 | 70% | 27.12 | 285 / 406 |
pancreas | 93% | 96.22 | 305 / 328 | 34% | 1.50 | 60 / 178 |
kidney | 100% | 3209.42 | 89 / 89 | 16% | 5.93 | 141 / 901 |
intestine | 95% | 76.57 | 915 / 966 | 3% | 0.15 | 18 / 527 |
adrenal gland | 39% | 136.27 | 101 / 258 | 55% | 22.56 | 126 / 230 |
skin | 71% | 90.42 | 1293 / 1809 | 1% | 0.02 | 3 / 472 |
esophagus | 37% | 16.59 | 530 / 1445 | 10% | 0.26 | 18 / 183 |
uterus | 26% | 9.18 | 45 / 170 | 16% | 1.39 | 73 / 459 |
bladder | 38% | 12.29 | 8 / 21 | 3% | 0.27 | 16 / 504 |
prostate | 37% | 21.16 | 90 / 245 | 0% | 0.00 | 1 / 502 |
breast | 33% | 20.80 | 151 / 459 | 2% | 0.11 | 24 / 1118 |
adipose | 31% | 18.99 | 377 / 1204 | 0% | 0 | 0 / 0 |
thymus | 22% | 19.87 | 142 / 653 | 7% | 1.44 | 45 / 605 |
lung | 16% | 4.68 | 91 / 578 | 10% | 0.51 | 114 / 1155 |
stomach | 23% | 8.48 | 84 / 359 | 2% | 0.11 | 5 / 286 |
spleen | 24% | 13.98 | 58 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 13% | 14.31 | 123 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 11% | 7.05 | 151 / 1335 | 0% | 0 | 0 / 0 |
muscle | 11% | 4.03 | 85 / 803 | 0% | 0 | 0 / 0 |
ovary | 4% | 1.26 | 7 / 180 | 6% | 0.28 | 25 / 430 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.25 | 4 / 45 |
brain | 6% | 2.57 | 164 / 2642 | 1% | 0.29 | 10 / 705 |
eye | 0% | 0 | 0 / 0 | 4% | 0.12 | 3 / 80 |
heart | 1% | 0.34 | 7 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070873 | Biological process | regulation of glycogen metabolic process |
GO_0007584 | Biological process | response to nutrient |
GO_0006091 | Biological process | generation of precursor metabolites and energy |
GO_0007188 | Biological process | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
GO_0008217 | Biological process | regulation of blood pressure |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0009267 | Biological process | cellular response to starvation |
GO_0042594 | Biological process | response to starvation |
GO_0006887 | Biological process | exocytosis |
GO_0071377 | Biological process | cellular response to glucagon stimulus |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0042593 | Biological process | glucose homeostasis |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005768 | Cellular component | endosome |
GO_0004967 | Molecular function | glucagon receptor activity |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0017046 | Molecular function | peptide hormone binding |
Gene name | GCGR |
Protein name | Glucagon receptor Glucagon receptor (GL-R) |
Synonyms | |
Description | FUNCTION: G-protein coupled receptor for glucagon that plays a central role in the regulation of blood glucose levels and glucose homeostasis. Regulates the rate of hepatic glucose production by promoting glycogen hydrolysis and gluconeogenesis. Plays an important role in mediating the responses to fasting. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Promotes activation of adenylate cyclase. Besides, plays a role in signaling via a phosphatidylinositol-calcium second messenger system. . |
Accessions | I3L454 P47871 ENST00000400723.8 ENST00000573428.1 I3L1L8 ENST00000570996.5 ENST00000671794.1 |